ResMed Inc RMD

Morningstar Rating
$252.86 −0.20 (0.08%)
View Full Chart

Company Report

Price vs Fair Value

RMD is trading within a range we consider fairly valued.
Price
$252.86
Fair Value
V^^
Uncertainty
LOCK|nV%Z
1-Star Price
LOCK|GD
5-Star Price
LOCK|C@
Economic Moat
LOCK|>yGKx
Capital Allocation
LOCK|wVShtchL

Bulls Say, Bears Say

Bulls

Home sleep tests and ResMed's training of primary care doctors make diagnosis quicker and cheaper, bringing more of the untreated population into therapy.

Bears

Philips is likely to return to the US in 2027 and price aggressively to win back share, which could pressure ResMed's prices.

News

Articles & Videos

Trading Information

Previous Close Price
$253.06
Day Range
$248.72–255.57
52-Week Range
$180.27–277.67
Bid/Ask
$221.00 / $260.00
Shares Outstanding
140.64M
Market Cap
$35.56B
Volume/Avg
1M / 1M

Key Statistics

Price/Earnings (Normalized)
22.64
Price/Sales
6.53
Dividend Yield (Trailing)
0.97%
Dividend Yield (Forward)
1.04%
Dividend Payment Schedule
Mar, Jun, Sep, Dec
Total Yield
2.73%

Company Profile

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
11,370

Competitors

Valuation

Metric
RMD
GETI B
MDT
Price/Earnings (Normalized)
22.6422.5816.86
Price/Book Value
5.542.232.43
Price/Sales
6.532.123.27
Price/Cash Flow
19.6413.7513.69
Price/Earnings
RMD
GETI B
MDT

Financial Strength

Metric
RMD
GETI B
MDT
Quick Ratio
1.830.721.29
Current Ratio
3.101.252.07
Interest Coverage
—7.9110.12
Quick Ratio
RMD
GETI B
MDT

Profitability

Metric
RMD
GETI B
MDT
Return on Assets (Normalized)
19.09%6.11%8.31%
Return on Equity (Normalized)
25.91%11.50%15.59%
Return on Invested Capital (Normalized)
22.30%9.40%10.57%
Return on Assets
RMD
GETI B
MDT

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|@$y<fTx#LOCK|rdN$160B
Becton Dickinson & Co
BDX
LOCK|x&LOCK|P%?#$54B
Alcon Inc
ALC
LOCK|%ZZb@CLOCK|c>$K^$34B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|!^GWmg?LOCK|&^Gn$30B
West Pharmaceutical Services Inc
WST
LOCK|GL>h@%dLOCK|yX&$28B
Solventum Corp
SOLV
LOCK|!h?Hz@lLOCK|%>$15B
Baxter International Inc
BAX
LOCK|P^LOCK|q@kc$13B
The Cooper Companies Inc
COO
LOCK|mfQ&RXLOCK|jP&>C$12B
Repligen Corp
RGEN
LOCK|@&BSW@<LOCK|&!>?>$11B

Sponsor Center